专利检索 ap:("OCHSNER CLINIC FOUNDATION") AND inv:"Richard N. RE, M.D." 第 1 页

1.

发明公开
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) INHIBITORS IN THE TREATMENT OF PANCREATIC DUCTAL CARCINOMA 审中-公开

公开(公告)号：US20240226089A1

公开(公告)日：2024-07-11

申请号：US18095384

申请日：2023-01-10

申请人： OCHSNER CLINIC FOUNDATION

发明人： Richard N. RE, M.D. , Xin ZHANG, M.D., Ph.D. , Li LI, M.D., Ph.D.

IPC分类号： A61K31/472 , A61K31/4178 , A61K31/4184 , A61K31/437 , A61P1/18 , A61P35/00

CPC分类号： A61K31/472 , A61K31/4178 , A61K31/4184 , A61K31/437 , A61P1/18 , A61P35/00

摘要： Embodiments provide for methods of treatment for subjects suffering from a condition/disorder or disease for which the renin-angiotensin-aldosterone system (RAAS) plays at least some role. In one example, a method comprises administering to the subject an effective amount of one or more of an angiotensin receptor AT2R antagonist for a duration sufficient to elicit a desired response in the subject suffering from pancreatic cancer. The administering acts to reduce proliferation of tumor cells associated with the pancreatic cancer.